De
DeepMind (Google)
Free for non-commercial use
Documentation ProvidedRegulatory Status Disclosed
Overview
DeepMind’s AlphaFold is an artificial intelligence (AI) tool that predicts the 3D structures of proteins and other biomolecules with high accuracy. It utilizes deep learning, an advanced form of machine learning, to analyze the one-dimensional amino acid sequence of a protein and predict its complex three-dimensional shape.
- What it does: AlphaFold predicts the 3D structures of proteins, DNA, RNA, ligands, and their interactions. This capability extends to predicting how these molecules interact within cells.
- Who it is for: AlphaFold is primarily a research tool for scientists in various fields, including drug discovery, disease modeling, genomics, and biotechnology. It is used by researchers globally in academic and non-commercial settings.
- How it fits a clinical or practice workflow: While not a direct clinical tool, AlphaFold accelerates foundational research that can inform clinical practice. For example, by predicting protein structures, it aids in identifying potential drug targets and understanding disease mechanisms, which can lead to the development of new treatments and diagnostics. Researchers can access AlphaFold through the AlphaFold Server for non-commercial use or explore the AlphaFold Protein Structure Database, which contains over 200 million predicted structures.
- Notable capabilities: AlphaFold has been recognized for solving the 50-year-old “protein-folding problem,” significantly reducing the time and cost associated with determining protein structures experimentally. Its predictions are often comparable in accuracy to experimental methods. The AlphaFold Protein Structure Database provides open access to a vast collection of predicted protein structures, accelerating scientific discovery on a global scale.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- High-accuracy protein structure prediction
- Prediction of protein-molecule interactions
- Database of over 200 million protein structures
- Open access for non-commercial research
- Model code and weights available for academic use
- Accelerates drug discovery and biological research
Use Cases
- Understanding disease mechanisms (e.g., cancer, Parkinson's, heart disease)
- Drug discovery and development
- Engineering resilient crops
- Developing plastic-eating enzymes
- Fighting antibiotic resistance
- Studying protein evolution
What Physicians Need to Know
Physician Tip
Physicians should understand that AlphaFold is a powerful research tool for understanding protein structures and functions, which underpins much of modern medicine and drug development. While it doesn't directly assist in clinical decision-making at the point of care, its contributions are foundational to developing new diagnostics and therapies. Stay informed about how structural biology insights, enabled by tools like AlphaFold, are translating into clinical practice.
AlphaFold's primary integrations are with bioinformatics platforms, research databases, and drug discovery pipelines. It provides predicted protein structures that can be utilized by other computational tools for molecular docking, drug design, and understanding disease pathogenesis. It is not designed for integration with Electronic Health Records (EHRs) or direct clinical decision support systems.
Details
| Category | Clinical Decision Support & Reference, Drug Discovery & Research, Lab & Diagnostics |
| Pricing |
Free for non-commercial use
|
| Free Trial | Unknown |
| Deployment | Cloud-based (AlphaFold Server, Google Colab, Google Cloud's Vertex AI, BigQuery), On-premise (via open-source code on GitHub with significant computational resources) |
| API Available | Yes |
| Data Export | Unknown |
| Languages | English (primary for documentation and interfaces) |
| Training | Unknown |
| Target Size | Researchers, academic and non-commercial organizations, pharmaceutical companies (for commercial drug discovery via Isomorphic Labs). |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Not applicable AI-estimated AlphaFold 2 and its output are for theoretical modeling only and are not intended, validated, or approved for clinical use. |
| Integrations | |
| EHR | Not specified |
| Specialties | Endocrinology, Infectious Disease, Oncology |
Social Proof
| Customers | Over 3 million researchers from over 190 countries use AlphaFold. |
| Notable | Isomorphic Labs (collaborating on drug design)Royal Free NHS Trust (past partnership for optimizing healthcare systems)Klarna (used AlphaEvolve to improve training speed and performance)Oak Ridge National Laboratory (partnered to deploy AlphaEvolve on Frontier supercomputer) |
Support & Reliability
| Training Provided | Unknown |
What the Web Says
DeepMind's AlphaFold, particularly AlphaFold 2 and 3, is widely recognized as a revolutionary AI system for predicting protein structures and interactions. It has significantly accelerated biomedical research, drug discovery, and our understanding of diseases by providing highly accurate 3D protein models in a fraction of the time and cost of traditional experimental methods. While generally praised for its transformative impact, some experts express concerns about its limitations, commercialization, and potential for overestimation.
Overall: PositiveStrengths
- Accurate prediction of protein structures, rivaling experimental methods.
- Significantly reduces the time and cost associated with determining protein structures.
- Accelerates drug discovery and development by identifying potential targets and predicting drug-target interactions.
- Expanded database of over 200 million protein structures, making them publicly accessible and advancing research globally.
- Contributes to understanding and treating various diseases, including Alzheimer's, Parkinson's, cancer, and neglected diseases.
- AlphaFold 3 extends predictions beyond proteins to include DNA, RNA, and ligands, with improved accuracy for complex molecular interactions.
Limitations
- AlphaFold 3 is closed-source and heavily restricted, limiting its use for commercial purposes and custom protein predictions.
- May not be reliable for critical work requiring high certainty, and struggles with predicting membrane proteins and some barrel proteins.
- Accuracy can be insufficient for a third of its predictions, and it doesn't always reveal the underlying mechanisms of protein folding.
- AI models can depend on incomplete or biased datasets, potentially limiting reliability, especially for rare diseases.
- Predicted binding-site detail is often not accurate enough for confident chemistry decisions in drug design.
- Struggles with complexes involving large conformational changes and displays conformational biases for some target classes.
Based on reviews from: Wisterm, Reddit, PubMed, ToolJunction, AI Agent Store, Best AI Tools To Use, The Guardian, Business Insider, Medium, News Medical, Darden Report, Google DeepMind, LessWrong, Gain Therapeutics, Iron Software, MIT Technology Review, The Sequence, Wikipedia, Facebook, DDN, PMC - NIH
Last updated: 2026-10-12
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate DeepMind (Google)
Press & Coverage
Google Blog
AlphaFold 3 predicts the structure and interactions of all of life's molecules - Google Blog
Google DeepMind and Isomorphic Labs launched AlphaFold 3, an AI model that accurately predicts the structure and interactions of proteins, DNA, RNA, and ligands, aiming to transform drug discovery and biological understanding.
2024-05
The Guardian
Google DeepMind's 'leap forward' in AI could unlock secrets of biology - The Guardian
AlphaFold 3, developed by Google DeepMind, can predict how proteins interact with various molecules, including DNA and drugs, with significantly improved accuracy, potentially accelerating research in areas like cancer therapies and crop resilience.
2024-05
PMC (PubMed Central)
Review of AlphaFold 3: Transformative Advances in Drug Design and Therapeutics - PMC
This peer-reviewed article highlights AlphaFold 3's transformative impact on drug design and therapeutics due to its unparalleled accuracy in predicting biomolecular interactions, extending beyond proteins to DNA, RNA, and ligands.
2024-07
PMC (PubMed Central)
The transformative impact of AI-enabled AlphaFold 3: evolution, current status, and future prospects in structural biology - PMC
This review discusses the evolution of AlphaFold, emphasizing AlphaFold 3's substantial advancement in modeling complex biomolecular interactions, including proteins, small molecules, ions, DNA/RNA, and modified residues.
2024-07
Google DeepMind
AlphaFold: Five Years of Impact - Google DeepMind
Five years after AlphaFold 2 solved the protein structure prediction problem, DeepMind reflects on its impact, including accelerating scientific discovery, fueling biological research, and its recognition with a Nobel Prize.
2025-11
European Molecular Biology Laboratory (EMBL)
EMBL-EBI and Google DeepMind renew partnership and release update to AlphaFold Database
EMBL-EBI and Google DeepMind renewed their collaboration on the AlphaFold Protein Structure Database, updating it with the latest protein sequence data to continue providing high-quality protein structure predictions to the global scientific community.
2025-10
Engadget
Google DeepMind disbands its Nobel-prize winning AlphaFold team - Engadget
Google DeepMind has reportedly disbanded the dedicated team behind its Nobel Prize-winning AlphaFold program, reassigning members to other projects like Gemini, though the AlphaFold technology and database remain operational.
2026-07
Singularity Hub
Google DeepMind Gives AI-Designed Proteins a Watermark - Singularity Hub
Google DeepMind introduced SynthID Bio, a new system to watermark AI-designed proteins, aiming to address biosecurity risks and prevent the pollution of scientific databases with AI-generated structures.
2026-10
Videos
Product demos, reviews, and walkthroughs for DeepMind (Google).
Loading videos...
Frequently Asked Questions
DeepMind's AI tools, such as AlphaFold, can provide insights into protein structures, which can be crucial for understanding disease mechanisms and drug discovery. Additionally, other DeepMind projects have explored areas like predicting acute kidney injury, potentially offering early warnings and supporting timely interventions in patient care.
DeepMind's healthcare projects often involve collaborations with NHS trusts and other medical institutions, with research published in peer-reviewed journals demonstrating their efficacy in specific applications. Compliance with medical regulations, including data privacy standards like GDPR, is a critical aspect of their development and deployment, particularly when handling sensitive patient information.
Yes, numerous other companies and research institutions are developing AI tools for clinical decision support, ranging from diagnostic aids to treatment recommendation systems. These alternatives often specialize in different medical domains and utilize various AI methodologies, requiring physicians to evaluate them based on their specific needs, validation studies, and integration capabilities with existing workflows.
The pricing models for DeepMind's healthcare AI solutions are not publicly disclosed and would likely depend on the specific product, scope of implementation, and partnership agreements. Integration into a hospital's budget would necessitate a clear understanding of the value proposition, potential cost savings through improved efficiency or outcomes, and negotiation with DeepMind or Google Health.
Current limitations include the need for extensive, high-quality data for training, the potential for algorithmic bias if training data is not representative, and the challenge of integrating AI recommendations seamlessly into complex clinical workflows. Ethical considerations encompass data privacy, accountability for AI-driven decisions, transparency in how AI arrives at its recommendations, and ensuring that AI augments rather than replaces human clinical judgment.
DeepMind, as part of Google Health, adheres to stringent data governance policies and regulatory frameworks like GDPR and HIPAA. They employ robust anonymization and encryption techniques, and often work with de-identified data or through secure data-sharing agreements with healthcare providers to protect patient privacy.
The availability of technical support and training would typically be part of the implementation agreement between DeepMind/Google Health and the healthcare institution. This would likely include comprehensive onboarding, ongoing technical assistance, and educational resources to ensure effective and appropriate use of the AI tools by clinical staff.
Suggest an Edit →
| Last Verified: 2026-10-12 | First Added: 2026-10-11